{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:25:24Z","timestamp":1790259924595,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","award":["2022-2023"],"award-info":[{"award-number":["2022-2023"]}],"id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006601","name":"Governo Italiano Ministero degli Affari Esteri e della Cooperazione Internazionale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.aohep.2023.101153","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T13:23:18Z","timestamp":1695129798000},"page":"101153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Stemness markers in hepatocellular carcinoma of Eastern vs. Western population: Etiology matters?"],"prefix":"10.1016","volume":"29","author":[{"given":"Caecilia HC","family":"Sukowati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korri","family":"El-Khobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chyntia Olivia Maurine","family":"Jasirwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juferdy","family":"Kurniawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rino Alvani","family":"Gani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2023.101153_bib0001","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2023.101153_bib0002","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.aohep.2023.101153_bib0003","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.aohep.2023.101153_bib0004","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2023.101153_bib0005","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2023.101153_bib0006","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","article-title":"Epidemiology and management of hepatocellular carcinoma","volume":"156","author":"Kulik","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2023.101153_bib0007","unstructured":"World Health Organization. Global hepatitis report, 2017. https:\/\/www.who.int\/publications-detail-redirect\/9789241565455; 2023 [accessed April 20, 2023]."},{"key":"10.1016\/j.aohep.2023.101153_bib0008","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S2468-1253(19)30342-5","article-title":"Liver diseases in the Asia-Pacific region: a lancet gastroenterology & hepatology commission","volume":"5","author":"Sarin","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2023.101153_bib0009","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jhep.2018.10.008","article-title":"Hepatocellular carcinoma in the setting of alcohol-related liver disease","volume":"70","author":"Ganne-Carri\u00e9","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2023.101153_bib0010","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.16248","article-title":"Alcohol and its associated liver carcinogenesis","author":"Jacob","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2023.101153_bib0011","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1101\/gr.220038.116","article-title":"Genome-scale mutational signatures of aflatoxin in cells, mice, and human tumors","volume":"27","author":"Huang","year":"2017","journal-title":"Genome Res"},{"key":"10.1016\/j.aohep.2023.101153_bib0012","article-title":"A call for unity: the path towards a more precise and patient-centric nomenclature for NAFLD","volume":"28","year":"2023","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.aohep.2023.101153_bib0013","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HEP.0000000000000412","article-title":"A call for unity: the path towards a more precise and patient-centric nomenclature for NAFLD","volume":"78","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101153_bib0014","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2023.101153_bib0015","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jhep.2021.09.024","article-title":"Asian perspective on NAFLD-associated HCC","volume":"76","author":"Yip","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2023.101153_bib0016","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3350\/cmh.2022.0239","article-title":"Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical Bayesian approach","volume":"28","author":"Le","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.aohep.2023.101153_bib0017","doi-asserted-by":"crossref","first-page":"2","DOI":"10.21037\/cco-20-162","article-title":"Epidemiology, mutational landscape and staging of hepatocellular carcinoma","volume":"10","author":"Fenton","year":"2021","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.aohep.2023.101153_bib0018","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1002\/cncr.30237","article-title":"Comparison of hepatocellular carcinoma in Eastern versus Western populations","volume":"122","author":"Choo","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.aohep.2023.101153_bib0019","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/ng.2291","article-title":"Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators","volume":"44","author":"Fujimoto","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.aohep.2023.101153_bib0020","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ng.2256","article-title":"Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma","volume":"44","author":"Guichard","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.aohep.2023.101153_bib0021","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jhep.2012.10.006","article-title":"Next generation sequencing of HCC from European and Asian HCC cohorts. Back to p53 and Wnt\/\u03b2-catenin","volume":"58","author":"Teufel","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2023.101153_bib0022","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.3892\/ol.2020.11332","article-title":"Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy","volume":"19","author":"Lombardo","year":"2020","journal-title":"Oncol Lett"},{"issue":"Suppl 1","key":"10.1016\/j.aohep.2023.101153_bib0023","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101153_bib0024","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/liv.15251","article-title":"Changing epidemiology of hepatocellular carcinoma in Asia","volume":"42","author":"Zhang","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2023.101153_bib0025","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.3390\/cancers14184473","article-title":"Changes in the epidemiology of hepatocellular carcinoma in Asia","volume":"14","author":"Liu","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.aohep.2023.101153_bib0026","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1158\/1078-0432.CCR-18-0088","article-title":"Multimodal meta-analysis of 1,494 hepatocellular carcinoma samples reveals significant impact of consensus driver genes on phenotypes","volume":"25","author":"Chaudhary","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.aohep.2023.101153_bib0027","doi-asserted-by":"crossref","first-page":"59455","DOI":"10.18632\/oncotarget.19755","article-title":"Genomic variants link to hepatitis C racial disparities","volume":"8","author":"Yeh","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.aohep.2023.101153_bib0028","doi-asserted-by":"crossref","first-page":"40491","DOI":"10.18632\/oncotarget.9636","article-title":"Differences in somatic mutation landscape of hepatocellular carcinoma in Asian American and European American populations","volume":"7","author":"Yao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.aohep.2023.101153_bib0029","doi-asserted-by":"crossref","first-page":"6674","DOI":"10.3748\/wjg.v23.i36.6674","article-title":"Genetic biomarkers for hepatocellular cancer risk in a Caucasian population","volume":"23","author":"De Mattia","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2023.101153_bib0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jhep.2019.08.017","article-title":"Advances in molecular classification and precision oncology in hepatocellular carcinoma","volume":"72","author":"Rebouissou","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2023.101153_bib0031","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/hep.27722","article-title":"Characterization of the genotype and integration patterns of hepatitis B virus in early- and late-onset hepatocellular carcinoma","volume":"61","author":"Yan","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101153_bib0032","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1111\/liv.12807","article-title":"Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma","volume":"35","author":"Saitta","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2023.101153_bib0033","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.cgh.2019.08.045","article-title":"Frequent integration of HBV DNA in genomes of hepatocellular carcinoma cells from patients with occult infections","volume":"18","author":"Wong","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2023.101153_bib0034","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.3390\/ijms22083820","article-title":"Sex and race-related DNA methylation changes in hepatocellular carcinoma","volume":"22","author":"Ye","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.aohep.2023.101153_bib0035","doi-asserted-by":"crossref","DOI":"10.1177\/1758835918816287","article-title":"Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies","volume":"10","author":"Wang","year":"2018","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.aohep.2023.101153_bib0036","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/j.gastro.2013.03.013","article-title":"Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types","volume":"145","author":"Holczbauer","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2023.101153_bib0037","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrc4017","article-title":"Functional and genetic deconstruction of the cellular origin in liver cancer","volume":"15","author":"Marquardt","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.aohep.2023.101153_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.691410","article-title":"Emerging regulatory mechanisms involved in liver cancer stem cell properties in hepatocellular carcinoma","volume":"9","author":"Lv","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.aohep.2023.101153_bib0039","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41575-021-00508-3","article-title":"Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications","volume":"19","author":"Lee","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2023.101153_bib0040","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.reth.2021.03.002","article-title":"Liver cancer stem cells: recent progress in basic and clinical research","volume":"17","author":"Yamashita","year":"2021","journal-title":"Regen Ther"},{"key":"10.1016\/j.aohep.2023.101153_bib0041","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-030-14366-4_4","article-title":"Heterogeneity of hepatic cancer stem cells","volume":"1139","author":"Sukowati","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.aohep.2023.101153_bib0042","first-page":"2","article-title":"Oncogenicity of viral hepatitis B and C in the initiation of hepatic cancer stem cells","volume":"5","author":"Sukowati","year":"2019","journal-title":"Hepatoma Res"},{"key":"10.1016\/j.aohep.2023.101153_bib0043","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00261-017-1209-1","article-title":"Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis","volume":"43","author":"Tang","year":"2018","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.aohep.2023.101153_bib0044","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1096\/fj.05-5460rev","article-title":"Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis","volume":"20","author":"Rege","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.aohep.2023.101153_bib0045","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bbamcr.2006.08.008","article-title":"Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine\/growth factor responses","volume":"1763","author":"Rege","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.aohep.2023.101153_bib0046","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.acthis.2011.01.001","article-title":"Overexpression of Thy1\/CD90 in human hepatocellular carcinoma is associated with HBV infection and poor prognosis","volume":"113","author":"Lu","year":"2011","journal-title":"Acta Histochem"},{"key":"10.1016\/j.aohep.2023.101153_bib0047","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.3390\/cells9122672","article-title":"The mRNA distribution of cancer stem cell marker CD90\/Thy-1 is comparable in hepatocellular carcinoma of eastern and western populations","volume":"9","author":"Luong","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.aohep.2023.101153_bib0048","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/hep.26168","article-title":"Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma","volume":"57","author":"Yamashita","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101153_bib0049","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.canlet.2017.04.017","article-title":"Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of liver cancer stem cells","volume":"400","author":"Liu","year":"2017","journal-title":"Cancer Lett"},{"key":"10.1016\/j.aohep.2023.101153_bib0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jhep.2013.08.024","article-title":"The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma","volume":"60","author":"Zeng","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2023.101153_bib0051","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1056\/NEJMoa1300297","article-title":"Oncofetal gene SALL4 in aggressive hepatocellular carcinoma","volume":"368","author":"Yong","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aohep.2023.101153_bib0052","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4132\/jptm.2015.07.09","article-title":"SALL4 expression in hepatocellular carcinomas as associated with EpCAM-positivity and a poor prognosis","volume":"49","author":"Park","year":"2015","journal-title":"J Pathol Transl Med"},{"key":"10.1016\/j.aohep.2023.101153_bib0053","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1038\/onc.2016.399","article-title":"DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection","volume":"36","author":"Fan","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.aohep.2023.101153_bib0054","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/262385","article-title":"Serum SALL4 is a novel prognosis biomarker with tumor recurrence and poor survival of patients in hepatocellular carcinoma","volume":"2014","author":"Han","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.aohep.2023.101153_bib0055","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/PAS.0000000000000218","article-title":"SALL4 immunoreactivity predicts prognosis in Western hepatocellular carcinoma patients but is a rare event: a study of 236 cases","volume":"38","author":"Liu","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.aohep.2023.101153_bib0056","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg1695","article-title":"Pseudogene-mediated DNA demethylation leads to oncogene activation","volume":"7","author":"Kwon","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.aohep.2023.101153_bib0057","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0092-8674(89)90770-8","article-title":"Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice","volume":"59","author":"Chisari","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.aohep.2023.101153_bib0058","doi-asserted-by":"crossref","first-page":"13168","DOI":"10.1038\/s41598-018-31406-5","article-title":"Activation of hepatic stem cells compartment during hepatocarcinogenesis in a HBsAg HBV-transgenic mouse model","volume":"8","author":"Anfuso","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.aohep.2023.101153_bib0059","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/hep.29463","article-title":"Hepatitis B virus pregenomic RNA in hepatocellular carcinoma: A nosological and prognostic determinant","volume":"67","author":"Halgand","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101153_bib0060","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.830741","article-title":"Hepatitis B virus pregenomic RNA reflecting viral replication in distal non-tumor tissues as a determinant of the stemness and recurrence of hepatocellular carcinoma","volume":"13","author":"Xiao","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.aohep.2023.101153_bib0061","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.24675","article-title":"Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice","volume":"55","author":"Wang","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101153_bib0062","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1158\/0008-5472.CAN-10-3951","article-title":"Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells?","volume":"71","author":"Arzumanyan","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.aohep.2023.101153_bib0063","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1007\/s11427-017-9188-x","article-title":"Prognostic significance of combining high mobility group Box-1 and OV-6 expression in hepatocellular carcinoma","volume":"61","author":"Zhu","year":"2018","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.aohep.2023.101153_bib0064","doi-asserted-by":"crossref","first-page":"24005","DOI":"10.18632\/oncotarget.8209","article-title":"C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties","volume":"7","author":"Ng","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.aohep.2023.101153_bib0065","doi-asserted-by":"crossref","first-page":"23507","DOI":"10.18632\/oncotarget.15183","article-title":"C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3\/Nanog signaling pathway","volume":"8","author":"Ching","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.aohep.2023.101153_bib0066","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.clim.2009.10.007","article-title":"HCV-related hepatocellular carcinoma: from chronic inflammation to cancer","volume":"134","author":"Castello","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.aohep.2023.101153_bib0067","doi-asserted-by":"crossref","first-page":"13621","DOI":"10.1128\/JVI.02016-12","article-title":"Hepatitis C virus induces epithelial-mesenchymal transition in primary human hepatocytes","volume":"86","author":"Bose","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.aohep.2023.101153_bib0068","doi-asserted-by":"crossref","first-page":"11549","DOI":"10.1128\/JVI.01946-15","article-title":"Promotion of cancer stem-like cell properties in Hepatitis C virus iInfected hepatocytes","volume":"89","author":"Kwon","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.aohep.2023.101153_bib0069","doi-asserted-by":"crossref","first-page":"12292","DOI":"10.1128\/JVI.05920-11","article-title":"Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts","volume":"85","author":"Ali","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.aohep.2023.101153_bib0070","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1128\/JVI.80.2.866-874.2006","article-title":"Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6","volume":"80","author":"Machida","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.aohep.2023.101153_bib0071","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1073\/pnas.0807390106","article-title":"Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog","volume":"106","author":"Machida","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.aohep.2023.101153_bib0072","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-3-319-98788-0_8","article-title":"NANOG-dependent metabolic reprogramming and symmetric division in tumor-initiating stem-like cells","volume":"1032","author":"Machida","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.aohep.2023.101153_bib0073","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1053\/j.gastro.2015.11.002","article-title":"TLR4 signaling via NANOG cooperates with STAT3 to activate Twist1 and promote formation of tumor-initiating stem-like cells in livers of mice","volume":"150","author":"Uthaya Kumar","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2023.101153_bib0074","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1038\/s41467-020-16616-8","article-title":"p53 destabilizing protein skews asymmetric division and enhances NOTCH activation to direct self-renewal of TICs","volume":"11","author":"Choi","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.aohep.2023.101153_bib0075","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/518674","article-title":"TLRs, Alcohol, HCV, and tumorigenesis","volume":"2010","author":"Machida","year":"2010","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.aohep.2023.101153_bib0076","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/mc.22850","article-title":"Epithelial to mesenchymal transition is involved in ethanol promoted hepatocellular carcinoma cells metastasis and stemness","volume":"57","author":"Chen","year":"2018","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.aohep.2023.101153_bib0077","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.yexcr.2019.03.005","article-title":"TNF-\u03b1 derived from M2 tumor-associated macrophages promotes epithelial-mesenchymal transition and cancer stemness through the Wnt\/\u03b2-catenin pathway in SMMC-7721 hepatocellular carcinoma cells","volume":"378","author":"Chen","year":"2019","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.aohep.2023.101153_bib0078","first-page":"85","article-title":"Saturated fatty acid induces cancer stem cell-like properties in human hepatoma cells","volume":"61","author":"Chong","year":"2015","journal-title":"Cell Mol Biol"},{"key":"10.1016\/j.aohep.2023.101153_bib0079","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1002\/ctm2.379","article-title":"4-phenylbutyric acid promotes hepatocellular carcinoma via initiating cancer stem cells through activation of PPAR-\u03b1","volume":"11","author":"Chen","year":"2021","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.aohep.2023.101153_bib0080","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3892\/mmr.2020.11172","article-title":"Targeting protein palmitoylation decreases palmitate-induced sphere formation of human liver cancer cells","volume":"22","author":"Chong","year":"2020","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.aohep.2023.101153_bib0081","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4149\/neo_2014_025","article-title":"Transcriptome profiling of malignant transformed rat hepatic stem-like cells by aflatoxin B1","volume":"61","author":"Yang","year":"2014","journal-title":"Neoplasma"},{"key":"10.1016\/j.aohep.2023.101153_bib0082","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2011.05.035","article-title":"Hepatic oval cell lines generate hepatocellular carcinoma following transfection with HBx gene and treatment with aflatoxin B1 in vivo","volume":"311","author":"Li","year":"2011","journal-title":"Cancer Lett"},{"key":"10.1016\/j.aohep.2023.101153_bib0083","first-page":"466","article-title":"Interaction of hepatitis B virus X protein with the pregnane X receptor enhances the synergistic effects of aflatoxin B1 and hepatitis B virus on promoting hepatocarcinogenesis","volume":"9","author":"Niu","year":"2021","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.aohep.2023.101153_bib0084","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.4254\/wjh.v13.i12.1875","article-title":"Genotype E: the neglected genotype of hepatitis B virus","volume":"13","author":"Ingasia","year":"2021","journal-title":"World J Hepatol"},{"key":"10.1016\/j.aohep.2023.101153_bib0085","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000360947","article-title":"Genotypes and genetic variability of hepatitis B virus","volume":"57","author":"Kramvis","year":"2014","journal-title":"Intervirology"},{"key":"10.1016\/j.aohep.2023.101153_bib0086","article-title":"Molecular clones of genetically distinct hepatitis B virus genotypes reveal distinct host and drug treatment responses","volume":"4","author":"Liu","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.aohep.2023.101153_bib0087","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101153_bib0088","first-page":"235","article-title":"HCV genotypes and their determinative role in hepatitis C treatment","volume":"31","author":"Keikha","year":"2020","journal-title":"Virus Disease"},{"key":"10.1016\/j.aohep.2023.101153_bib0089","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/hep.32774","article-title":"Geographical similarity and differences in the burden and genetic predisposition of NAFLD","volume":"77","author":"Yip","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101153_bib0090","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1002\/hep.27372","article-title":"Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis","volume":"60","author":"Nault","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101153_bib0091","doi-asserted-by":"crossref","first-page":"8197","DOI":"10.7314\/APJCP.2014.15.19.8197","article-title":"Polymorphisms of TERT and CLPTM1L and the risk of hepatocellular carcinoma in Chinese males","volume":"15","author":"Su","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.aohep.2023.101153_bib0092","doi-asserted-by":"crossref","first-page":"684","DOI":"10.18632\/oncotarget.6331","article-title":"The TERT promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancer","volume":"7","author":"Ko","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.aohep.2023.101153_bib0093","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.redox.2018.10.018","article-title":"BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits","volume":"20","author":"Zhao","year":"2019","journal-title":"Redox Biol"},{"key":"10.1016\/j.aohep.2023.101153_bib0094","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jhep.2013.05.011","article-title":"Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing \u201cstemness\u201d-related markers","volume":"59","author":"Kim","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2023.101153_bib0095","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cld.2021.06.008","article-title":"Chronic hepatitis B virus in patients with chronic hepatitis C virus","volume":"25","author":"Airewele","year":"2021","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.aohep.2023.101153_bib0096","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1186\/s12885-020-07580-z","article-title":"Hepatocellular carcinoma: intratumoral EpCAM-positive cancer stem cell heterogeneity identifies high-risk tumor subtype","volume":"20","author":"Krause","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.aohep.2023.101153_bib0097","doi-asserted-by":"crossref","first-page":"11611","DOI":"10.1007\/s13277-016-5112-0","article-title":"Multiple roles of CD90 in cancer","volume":"37","author":"Kumar","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.aohep.2023.101153_bib0098","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fcell.2019.00066","article-title":"CD90\/Thy-1, a cancer-associated cell surface signaling molecule","volume":"7","author":"Sauzay","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.aohep.2023.101153_bib0099","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3390\/cells9061331","article-title":"Cancer stem sell functions in hepatocellular carcinoma and comprehensive therapeutic strategies","volume":"9","author":"Liu","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.aohep.2023.101153_bib0100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1158\/0008-5472.CAN-11-2235","article-title":"Immunomonitoring results of a phase II\/III study of malignant ascites patients treated with the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3)","volume":"72","author":"J\u00e4ger","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.aohep.2023.101153_bib0101","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41416-018-0150-6","article-title":"Randomised phase II trial to investigate catumaxomab (anti-EpCAM\u2009\u00d7\u2009anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer","volume":"119","author":"Kn\u00f6dler","year":"2018","journal-title":"Br J Cancer"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268123002569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268123002569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:46:07Z","timestamp":1761648367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268123002569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":101,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1665268123002569"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2023.101153","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stemness markers in hepatocellular carcinoma of Eastern vs. Western population: Etiology matters?","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2023.101153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101153"}}